Citizen Petitions: FDA Sees Increase In Requests For Reconsideration, Serial Filings
Executive Summary
FDA is concerned that the number of citizen petitions requesting reconsideration of agency decisions, the filing of serial petitions by the same firm, and requests from non-innovator companies could delay the approval of generics.
You may also be interested in...
Citizen Petitions Seeking To Delay Product Approvals Continue To Swamp FDA
Agency's latest report to Congress highlights resource burden, implies legislative fix may better discourage frivolous petitions.
Citizen Petitions Face Strict Certification Requirements Under FDA Final Guidance
FDA will reject petitions that do not include exact language for certification and verification; hedge fund manager files citizen petition opposing approval of Neoprobe's Lymphoseek.
Citizen Petitions Face Strict Certification Requirements Under FDA Final Guidance
FDA will reject petitions that do not include exact language for certification and verification; hedge fund manager files citizen petition opposing approval of Neoprobe's Lymphoseek.